PCRX
Pacira BioSciences, Inc.NASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.00B
P/E Ratio
145.31
EPS
$0.16
Beta
0.20
52W High
$27.64
52W Low
$18.80
50-Day MA
$22.12
200-Day MA
$23.55
Dividend Yield
—
Profit Margin
0.97%
Forward P/E
9.35
PEG Ratio
11.21
About Pacira BioSciences, Inc.
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United States. The company is headquartered in Parsippany, New Jersey.
Fundamentals
| Revenue (TTM) | $726.41M |
| Gross Profit (TTM) | $459.35M |
| EBITDA | $124.33M |
| Operating Margin | -1.17% |
| Return on Equity | 0.96% |
| Return on Assets | 1.48% |
| Revenue/Share (TTM) | $16.30 |
| Book Value | $16.86 |
| Price-to-Book | 1.33 |
| Price-to-Sales (TTM) | 1.38 |
| EV/Revenue | 1.513 |
| EV/EBITDA | 8.97 |
| Quarterly Earnings Growth (YoY) | -88.40% |
| Quarterly Revenue Growth (YoY) | 5.10% |
| Shares Outstanding | $40.49M |
| Float | $37.64M |
| % Insiders | 3.32% |
| % Institutions | 119.17% |
Analyst Ratings
Consensus ($28.71 target)
1
Strong Buy3
Buy2
Hold1
Strong SellData last updated: 4/9/2026